Sugi Predict

Sugi Predict / Compounds / SCHEMBL2147192

SCHEMBL2147192

SCHEMBL2147192

CC1(C)OB(c2cnc(-c3ccccc3)nc2)OC1(C)C

nearest known ligand 0.61

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ LIPG Q9Y5X9 9/20 0.61
▸ LPL P06858 8/20 0.61
▸ DGAT1 O75907 1/20 0.48
▸ NPC1 O15118 2/20 0.47
▸ NFKB1 P19838 2/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ NFKB2 Q00653 2/20 0.47
▸ RELA Q04206 2/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ PDGFRB P09619 1/20 0.43
▸ KDR P35968 1/20 0.43
▸ HPGDS O60760 4/20 0.41
▸ P4HB P07237 1/20 0.41
▸ ALPL P05186 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20068645 0.88 LPL (0.58) LIPGLPLDGAT1P4HB
SCHEMBL29688361 0.80 DGAT1 (0.70) LIPGLPLDGAT1PDGFRBKDR
SCHEMBL30739 0.80 DGAT1 (0.70) LIPGLPLDGAT1PDGFRBKDR
Biphenyl SCHEMBL28698489 0.80 LIPG (0.71) LIPGLPLDGAT1NPC1NFKB1
SCHEMBL12424884 0.79 LIPG (0.77) LIPGLPLDGAT1P4HB
SCHEMBL31378538 0.79 LPL (0.40) LIPGLPLDGAT1PDGFRBKDR
SCHEMBL400579 0.78 LIPG (0.51) LIPGLPLDGAT1NPC1RAB9A
SCHEMBL23327826 0.78 LIPG (0.80) LIPGLPLDGAT1P4HB
SCHEMBL23082128 0.78 LIPG (0.80) LIPGLPLDGAT1P4HB
SCHEMBL20995884 0.78 LIPG (0.80) LIPGLPLDGAT1P4HB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917903-B2 Metal complexes UDC IRELAND LIMITED (IE) 2024-02-27 — — US disclosed
CN-117534715-A Metal complex UDC爱尔兰有限公司 2024-02-09 — — CN disclosed
CN-111836820-B metal complex UDC爱尔兰有限公司 2023-12-12 — — CN disclosed
EP-3768692-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2022-08-17 — — EP disclosed
US-11024815-B2 Metal complexes MERCK PATENT GMBH (DE) 2021-06-01 — — US disclosed
US-20210111345-A1 METAL COMPLEXES UDC IRELAND LIMITED (IE) 2021-04-15 — — US disclosed
EP-3768692-A1 METAL COMPLEXES Merck Patent GmbH (DE) 2021-01-27 — — EP disclosed
US-10693077-B2 Compound and organic electronic device using the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2020-06-23 — — US disclosed
US-10693075-B2 Spiro compound and organic electronic device comprising the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2020-06-23 — — US disclosed
US-10483468-B2 Compound and organic electronic device using the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2019-11-19 — — US disclosed
US-20170213978-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2017-07-27 — — US disclosed
US-20170213978-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2017-07-27 — — US disclosed
US-9227971-B2 Pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors MERCK SHARP & DOHME CORP. (US) 2016-01-05 — — US disclosed
US-9227971-B2 Pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors MERCK SHARP & DOHME CORP. (US) 2016-01-05 — — US disclosed
US-9227971-B2 Pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors MERCK SHARP & DOHME CORP. (US) 2016-01-05 — — US disclosed
US-20120322791-A1 PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS MERCK SHARP & DOHME LLC 2012-12-20 — — US disclosed
US-20120322791-A1 PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS MERCK SHARP & DOHME LLC 2012-12-20 — — US disclosed
US-20120322791-A1 PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS MERCK SHARP & DOHME LLC 2012-12-20 — — US disclosed
WO-2011090935-A1 PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS MERCK SHARP & DOHME CORP. (US) 2011-07-28 — — WO disclosed
WO-2011090935-A1 PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS MERCK SHARP & DOHME CORP. (US) 2011-07-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10693075-B2 Spiro compound and organic electronic device comprising the same ESRRA, REN, ESRRB LIPG 4639/4885LPL 4507/4885DGAT1 4360/4885
US-20170213978-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME OR51E2, OR10J3, ESR1 LIPG 1415/4885LPL 3885/4885DGAT1 578/4885
US-10693077-B2 Compound and organic electronic device using the same SOD1, SCO2, RCOR3 LIPG 4440/4885LPL 4736/4885DGAT1 3783/4885
US-11024815-B2 Metal complexes EXOC4, EXOC3, TIMCC LIPG 4459/4885LPL 4682/4885DGAT1 1835/4885
US-20210111345-A1 METAL COMPLEXES NCLN, BICRA, AP3M1 LIPG 3983/4885LPL 3716/4885DGAT1 2190/4885
US-20120322791-A1 PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS MTOR, RICTOR, RPS6KA5 LIPG 4301/4885LPL 3792/4885DGAT1 4104/4885
US-11917903-B2 Metal complexes NCLN, BICRA, AP3M1 LIPG 3983/4885LPL 3716/4885DGAT1 2190/4885
US-10483468-B2 Compound and organic electronic device using the same ORC3, RBX1, CBX3 LIPG 4385/4885LPL 4748/4885DGAT1 4428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.